Combination of Intravitreal Injection of Ranibizumab and Photocoagulation for the Treatment of Aggressive Posterior Retinopathy of Prematurity with Vitreous Hemorrhage

Table 1

Characteristics of infants with AP-ROP associated with vitreous hemorrhage.

Patient number/eye		Gender	GA (weeks)	BW (g)	PCA (weeks), IVR	Zone before injection	Time after IVR (weeks), laser 1	Time after IVR (weeks), laser 2	Persistent ROP	Recurrence ROP
1	OD	M	27	1100	34	I	6			Y
	OS				34	I	8			Y
2	OD	M	28	1090	35	I	2	3	Y
	OS				35	Posterior II	6			Y
3	OD	M	28	1400	33	Posterior II	7			Y
4	OD	M	28	1000	36	I	2	3	Y
	OS				36	I	2		Y
5	OD	F	27	1250	34	I	7
	OS				34	I	7			Y
6	OD	M	28	900	36	I	2		Y
	OS				36	I	2		Y
7	OD	M	28	1250	36	I	2		Y
	OS				36	I	2		Y
8	OD	M	27	1125	33	I	9
	OS				33	I	9
9	OD	M	31	1500	36	I	2	3	Y
10	OD	M	32	1500	38	I	2	4	Y
	OS				38	I	2	4	Y
11	OD	M	32	1900	36	I	2		Y
	OS				36	I	2		Y
12	OD	M	27	1130	34	I	8			Y
	OS				34	I	8			Y
13	OD	M	28	1010	34	I	6			Y
	OS				34	I	6			Y
14	OS	M	29	1200	35	I	1	2	Y
15	OD	F	26	950	32	Posterior II	10			Y
	OS				32	Posterior II	10			Y
16	OD	M	28	1300	35	I	6			Y
	OS				35	I	2	4	Y
17	OD	F	28	1100	34	I	1	2	Y
	OS				34	I	4			Y
18	OD	M	27	1200	33	I	6
	OS				33	I	6			Y
19	OD	F	28	1300	34	I	2	4	Y
	OS				34	I	2	3	Y
20	OD	M	29	1220	34	I	8			Y
	OS				34	I	8			Y

AP-ROP: aggressive posterior retinopathy of prematurity; BW: birth weight; F: female; GA: gestational age; M: male; OD: right eye; OS: left eye; PCA: postconceptual age; Y: yes.